Back to search
Pigmented Lesions
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Pigmented Lesions trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Pigmented Lesions trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This observational, prospective cohort study aims to evaluate the diagnostic relevance of Reflectance Confocal Microscopy (RCM) features in atypical melanocytic…
This research study is creating a way to collect and store specimens and information from participants who may be at an increased risk of developing cancer, or…
The incidence of skin cancer has been continuously increasing over the past decades und the number of non melanoma skin cancer is well as melanoma is still goin…
The first IPL device obtained United States Food and Drug Administration (FDA) clearance in 1995 for treatment of lower extremity telangiectasias. Since then, i…
Pathologists provide the current gold standard in skin lesion diagnostics, most often primarily based on the interpretation of histological slides. Still, it ha…
It has been suggested that pathologists' diagnostic accuracy and confidence could be improved if they gained access to additional clinical information and in-vi…